Cytokinetics, Incorporated (CYTK)

NASDAQ: CYTK · Real-Time Price · USD

60.69

-0.91 (-1.48%)

At close: Apr 28, 2026, 4:00 PM EDT

60.70

+0.01 (0.02%)

After-hours: Apr 28, 2026, 4:50 PM EDT

Cytokinetics Market Cap

Cytokinetics has a market cap or net worth of $7.54 billion as of April 28, 2026. Its market cap has increased by 64.75% in one year.

Market Cap

7.54B

Enterprise Value

8.10B

1-Year Change

64.75%

Ranking

#1109

Market Cap Chart

Since April 30, 2004, Cytokinetics's market cap has increased from $419.30M to $7.54B, an increase of 1,698.23%. That is a compound annual growth rate of 14.03%.

Market Cap History

Date	Market Cap	% Change
Apr 28, 2026	7.47B	-3.78%
Dec 31, 2025	7.77B	39.94%
Dec 31, 2024	5.55B	-32.19%
Dec 29, 2023	8.19B	88.80%
Dec 30, 2022	4.34B	13.41%
Dec 31, 2021	3.82B	159.95%
Dec 31, 2020	1.47B	134.61%
Dec 31, 2019	626.90M	81.29%
Dec 31, 2018	345.80M	-21.27%
Dec 29, 2017	439.20M	-10.79%
Dec 30, 2016	492.30M	21.17%
Dec 31, 2015	406.30M	38.57%
Dec 31, 2014	293.20M	52.87%
Dec 31, 2013	191.80M	104.04%
Dec 31, 2012	94.00M	35.45%
Dec 30, 2011	69.40M	-49.60%
Dec 31, 2010	137.70M	-22.34%
Dec 31, 2009	177.30M	25.83%
Dec 31, 2008	140.90M	-39.40%
Dec 31, 2007	232.50M	-17.84%
Dec 29, 2006	283.00M	51.01%
Dec 30, 2005	187.40M	-35.49%
Dec 31, 2004	290.50M	-30.72%

View and export this data all the way back to 2004. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
ABIVAX Société Anonyme	8.98B
Bio-Techne	8.62B
Vaxcyte	8.59B
Nuvalent	8.18B
Krystal Biotech	8.03B
Halozyme Therapeutics	7.64B
ImmunityBio	7.53B
Kymera Therapeutics	7.08B

Market Cap Rankings